Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Infusion reaction")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 15 of 15

  • Page / 1
Export

Selection :

  • and

How to manage hypersensitivity reactions to biological agents?BARBAUD, Annick; GRANEL, Florence; WATON, Julie et al.EJD. European journal of dermatology. 2011, Vol 21, Num 5, pp 667-674, issn 1167-1122, 8 p.Article

The Safety of Concentrated Trastuzumab in 100 ml of Saline Solution for Administration to Patients with HER2-Positive Breast Cancer: A Phase 1 StudySENGOKU, Norihiko; TANINO, Hirokazu; WATANABE, Masahiko et al.Chemotherapy (Basel). 2014, Vol 60, Num 1, pp 1-6, issn 0009-3157, 6 p.Article

Risk factors for and pre-medications to prevent cetuximab-induced infusion reactions in patients with squamous cell carcinoma of the head and neckTOUMA, Waseem; KORO, Sami S; LEY, Jessica et al.Oral oncology (1997). 2014, Vol 50, Num 9, pp 895-900, issn 1368-8375, 6 p.Article

Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphomaSAITO, Bungo; NAKAMAKI, Tsuyoshi; ADACHI, Daisuke et al.International journal of hematology. 2004, Vol 80, Num 2, pp 164-167, issn 0925-5710, 4 p.Article

Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancerWASIF SAIF, Muhammad; SYRIGOS, K. I; HOTCHKISS, S et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 107-112, issn 0344-5704, 6 p.Article

Reacciones a la infusión de infliximab en pacientes dermatológicos = REACTIONS TO INFLIXIMAB INFUSIONS IN DERMATOLOGIC PATIENTS : CONSENSUS STATEMENT AND TREATMENT PROTOCOLPUIG, L; SAEZ, E; LOZANO, M. J et al.Actas dermo-sifiliográficas (Ed. impresa). 2009, Vol 100, Num 2, pp 103-112, issn 0001-7310, 10 p.Article

Comparison of novel methods for predicting the risk of pro-inflammatory clinical infusion reactions during monoclonal antibody therapyFINDLAY, Lucy; EASTWOOD, David; BALL, Christina et al.Journal of immunological methods. 2011, Vol 371, Num 1-2, pp 134-142, issn 0022-1759, 9 p.Article

Extensive forearm deep venous thrombosis following a severe infliximab infusion reactionRYAN, Barbara M; ROMBERG, Marielle; WOLTERS, Frank et al.European journal of gastroenterology & hepatology. 2004, Vol 16, Num 9, pp 941-942, issn 0954-691X, 2 p.Article

Review and expert opinion on prevention and treatment of infliximab-related infusion reactionsLECLUSE, L. L. A; PISKIN, G; MEKKES, J. R et al.British journal of dermatology (1951). 2008, Vol 159, Num 3, pp 527-536, issn 0007-0963, 10 p.Article

Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximabFOLEY, K. A; WANG, P. F; BARBER, B. L et al.Annals of oncology. 2010, Vol 21, Num 7, pp 1455-1461, issn 0923-7534, 7 p.Article

Safety of Infliximab Treatment in Patients with Rheumatoid Arthritis in a Real-world Clinical Setting: Description and Evaluation of Infusion ReactionsKELSALL, John; ROGERS, Pamela; GALINDO, Griselda et al.Journal of rheumatology. 2012, Vol 39, Num 8, pp 1539-1545, issn 0315-162X, 7 p.Article

Safety and Efficacy of Adalimumab in Pediatric Patients With Crohn DiseaseWYNESKI, Matthew J; GREEN, Alex; KAY, Marsha et al.Journal of pediatric gastroenterology and nutrition. 2008, Vol 47, Num 1, pp 19-25, issn 0277-2116, 7 p.Article

Infliximab Reintroduction is Not Associated to a Higher Rate of Immune-related Adverse Effects in Patients With Inflammatory Bowel Disease Initially Treated With a Three-infusion Induction RegimenDOMENECH, Eugeni; ZABANA, Yamile; MANOSA, Míriam et al.Journal of clinical gastroenterology. 2010, Vol 44, Num 1, pp 34-37, issn 0192-0790, 4 p.Article

Infliximab in Pediatric Rheumatology Patients: A Retrospective Analysis of Infusion Reactions and Severe Adverse Events During 2246 Infusions over 12 YearsAESCHLIMANN, Florence A; HOFER, Kevin D; SCHNEIDER, Elvira Cannizzaro et al.Journal of rheumatology. 2014, Vol 41, Num 7, pp 1409-1415, issn 0315-162X, 7 p.Article

Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysisLEE, Lennard Y. W; SANDERSON, Jeremy D; IRVING, Peter M et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 9, pp 1078-1085, issn 0954-691X, 8 p.Article

  • Page / 1